ClinicalTrials.gov

History of Changes for Study: NCT01839487
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
Latest version (submitted July 6, 2020) on ClinicalTrials.gov
  • A study version is represented by a row in the table.
  • Select two study versions to compare. One each from columns A and B.
  • Choose either the "Merged" or "Side-by-Side" comparison format to specify how the two study versions are to be displayed. The Side-by-Side format only applies to the Protocol section of the study.
  • Click "Compare" to do the comparison and show the differences.
  • Select a version's Submitted Date link to see a rendering of the study for that version.
  • The yellow A/B choices in the table indicate the study versions currently compared below. A yellow table row indicates the study version currently being viewed.
  • Hover over the "Recruitment Status" to see how the study's recruitment status changed.
  • Study edits or deletions are displayed in red.
  • Study additions are displayed in green.
Study Record Versions
Version A B Submitted Date Changes
1 April 24, 2013 None (earliest Version on record)
2 April 30, 2013 Contacts/Locations and Study Status
3 May 20, 2013 Contacts/Locations and Study Status
4 May 29, 2013 Study Status and Contacts/Locations
5 June 3, 2013 Study Status and Contacts/Locations
6 June 11, 2013 Contacts/Locations and Study Status
7 June 18, 2013 Contacts/Locations and Study Status
8 June 28, 2013 Contacts/Locations and Study Status
9 July 12, 2013 Contacts/Locations and Study Status
10 July 22, 2013 Contacts/Locations and Study Status
11 July 30, 2013 Contacts/Locations and Study Status
12 August 9, 2013 Contacts/Locations and Study Status
13 August 13, 2013 Contacts/Locations and Study Status
14 August 19, 2013 Contacts/Locations and Study Status
15 August 28, 2013 Contacts/Locations and Study Status
16 August 29, 2013 Contacts/Locations and Study Status
17 September 4, 2013 Study Status and Contacts/Locations
18 September 16, 2013 Contacts/Locations and Study Status
19 September 25, 2013 Outcome Measures, Contacts/Locations and Study Status
20 October 21, 2013 Study Status and Contacts/Locations
21 October 25, 2013 Contacts/Locations and Study Status
22 January 17, 2014 Contacts/Locations and Study Status
23 January 27, 2014 Contacts/Locations and Study Status
24 April 21, 2014 Recruitment Status, Contacts/Locations and Study Status
25 July 28, 2014 Recruitment Status, Contacts/Locations, Study Status, Study Description, Eligibility, Outcome Measures, Study Design and Conditions
26 February 5, 2015 Contacts/Locations and Study Status
27 March 24, 2015 Study Status and Contacts/Locations
28 August 25, 2015 Contacts/Locations, Study Status and Eligibility
29 October 14, 2015 Contacts/Locations, Study Status and Eligibility
30 February 3, 2016 Contacts/Locations and Study Status
31 February 5, 2016 Contacts/Locations and Study Status
32 February 25, 2016 Recruitment Status, Study Status, Contacts/Locations and Study Design
33 January 11, 2018 Study Status, Contacts/Locations and Study Design
34 October 17, 2018 Recruitment Status and Study Status
35 May 7, 2019 Study Status, Arms and Interventions, Study Identification, Study Description, Oversight and Eligibility
Show
Results Submission Events
36 July 6, 2020 Outcome Measures, Study Status, More Information, References, Document Section, Adverse Events, Baseline Characteristics, Participant Flow, Contacts/Locations and Study Description
Comparison Format:

U.S. National Library of Medicine | U.S. National Institutes of Health | U.S. Department of Health & Human Services